| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/04/2007 | CN1939282A Amlodipine benesanli dropping balls and production thereof |
| 04/04/2007 | CN1308459C Process for producing casein peptide using coarse cheese as raw material |
| 04/04/2007 | CN1308438C Compositions including ammonia oxidizing bacteria and methods of using same |
| 04/04/2007 | CN1308431C Buck-wheat flavone vinega soft capsule and preparing method |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308321C Jujube kernel saponin derivative and its preparation method and use |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308317C New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/04/2007 | CN1308311C Novel pyridine- and quinoline-derivatives |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308307C Pseudopolymorphic forms of carvedilol |
| 04/04/2007 | CN1308035C Application of human urine kininogenase for preparing medicine to treat acute coronary disease |
| 04/04/2007 | CN1308030C Pharmaceutical composition containing effective part of 'Ruyi Jinhuang Powder' and preparation method thereof |
| 04/04/2007 | CN1308023C Medicine for treating congestive heart failure and its preparation method |
| 04/04/2007 | CN1308022C Chinese medicinal oral liquid for preventing and treating apoplexy sequelae |
| 04/04/2007 | CN1308012C Chinese medicine composition for treating cerebral hemorrhage and its preparation process |
| 04/04/2007 | CN1308011C Method for extracting ganoderma lucidum spore fat soluble active substance |
| 04/04/2007 | CN1308009C Health care product having blood pressure regulating function |
| 04/04/2007 | CN1308008C Pharmaceutical composition for treating coronary heart disease |
| 04/04/2007 | CN1308005C Medicinal tea with function of reducing blood pressure |
| 04/04/2007 | CN1308002C Compound preparation of notoginseng total saponin and quzaqi aglycone and its preparing method |
| 04/04/2007 | CN1307989C Use of phytanic acid for treating diabetes |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307980C Lemai dripping pill for treating cardiovascular diseases and its preparing method |
| 04/04/2007 | CN1307976C Thorax comforting drop pills for treating cardiopathy and preparation method thereof |
| 04/04/2007 | CN1307975C Safflower drop pills and preparation method thereof |
| 04/04/2007 | CN1307903C Fruit/vegetable coarse fibre composition and processing method and application thereof |
| 04/03/2007 | US7200531 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199247 Amide derivative of amlodipine |
| 04/03/2007 | US7199239 Chemical compounds |
| 04/03/2007 | US7199228 Nucleotide sequences comprising nebularine, hypoxanthine and uracil; antitumor agents; antiproliferative agents; anticarcinogenic agents; antiinflammatory agents |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199122 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis |
| 04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | US7198254 System for producing micro-cluster liquids |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2344053C Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| 04/03/2007 | CA2296586C New 2,3-benzodiazepine derivatives |
| 04/03/2007 | CA2180660C Novel piperidine derivatives with paf antagonist activity |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 03/29/2007 | WO2007034846A1 Cardiotonic agent comprising grk inhibitor |
| 03/29/2007 | WO2007034784A1 Ctgf gene expression inhibitor |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007033773A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |
| 03/29/2007 | WO2007010337A3 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors |
| 03/29/2007 | WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072907 Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity |
| 03/29/2007 | US20070072865 Bicyclic piperazine compound and use thereof |
| 03/29/2007 | US20070072826 Compositions and methods for modulation of vascular structure and/or function |
| 03/29/2007 | US20070072818 Endothelial growth factors; antiischemic agents; neovascularization |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070071837 Treatment of aspirin resistance with radix salviae mitiorhizae, its extract and composition |
| 03/29/2007 | US20070071834 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071725 Nitric oxide synthase gene transfer |
| 03/29/2007 | DE102005045829A1 Mittel enthaltend langkettige Alkohole zur Suppression der Konzentrationen des C-reaktiven Proteins (CRP) im menschlichen Blut Compositions comprising long-chain alcohols for the suppression of the concentrations of C-reactive protein (CRP) in human blood |
| 03/29/2007 | CA2623462A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767619A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767534A1 Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia |
| 03/28/2007 | EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor |
| 03/28/2007 | EP1767223A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767222A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767215A1 Isoflavones against radiation-induced mortality |
| 03/28/2007 | EP1767209A1 Neuroprotective drug |
| 03/28/2007 | EP1767207A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767206A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767198A1 Regulator of physiological function of ghrelin and use thereof |
| 03/28/2007 | EP1765852A1 Method and composition for treating angiogenesis and for preventing cancer progression and metastasis comprising a prostate secretory protein (psp94) family member |
| 03/28/2007 | EP1765832A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 03/28/2007 | EP1765831A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 03/28/2007 | EP1765381A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/28/2007 | EP1765366A2 Sulphated depolymerised derivates of exopolysaccharides (eps), preparation and uses thereof |
| 03/28/2007 | EP1765357A2 Use of atp analogues for treatment of cardiovascular diseases |
| 03/28/2007 | EP1765319A1 Essential fatty acids in the prevention and/or treatment of depression in patients with coronary heart or artery disease |
| 03/28/2007 | EP1663267B1 Oral compositions for the treatment of cellulite |
| 03/28/2007 | EP1513555B1 Formulations of quinapril and related ace inhibitors |
| 03/28/2007 | EP1497294B1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 03/28/2007 | EP1453532A4 Taojiks as modifiers of the beta-catenin pathway and methods of use |